Toll-Like Receptor 4 (TLR4)
<div class="infobox" style="float:right; width:280px; padding:10px; border:1px solid #ddd; margin:0 0 10px 10px; background:#f9f9f9;">
<h3 style="margin-top:0; border-bottom:1px solid #ccc;">TLR4</h3>
<table style="width:100%; font-size:0.9em;">
<tr><td><b>Gene</b></td><td>[TLR4](/genes/tlr4)</td></tr>
<tr><td><b>UniProt</b></td><td>[O00206](https://www.uniprot.org/uniprot/O00206)</td></tr>
<tr><td><b>MW</b></td><td>95 kDa</td></tr>
<tr><td><b>Location</b></td><td>Cell membrane, endosomes</td></tr>
<tr><td><b>PDB</b></td><td>[3FXI](https://www.rcsb.org/structure/3FXI)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-f3fb3b91" style="color:#ce93d8" title="Score: 0.71">Selective TLR4 Modulation to Prevent Gut...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1290 edges</a></td>
</tr>
</table>
</div>
Pathway Diagram
Mermaid diagram (expand to render)
Overview
Toll-like receptor 4 (TLR4) is a pattern recognition receptor that serves as the primary sensor for bacterial lipopolysaccharide (LPS). Expressed on [microglia](/cell-types/microglia-neuroinflammation), [astrocytes](/entities/astrocytes), and peripheral immune cells, [TLR4](/entities/tlr4) triggers innate immune responses through MyD88-dependent and TRIF-dependent signaling pathways. In the CNS, TLR4 mediates neuroinflammation and has been implicated in the pathogenesis of Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions.
Structure and Domains
TLR4 is a type I transmembrane receptor with:
- Leucine-rich repeats (LRR): 22 extracellular LRRs form the ligand-binding ectodomain
- Ectodomain: Horseshoe-shaped structure for LPS and DAMP recognition
- Transmembrane domain: Single-pass membrane anchor
- TIR domain: C-terminal cytoplasmic domain for adaptor recruitment
MD-2 Association
TLR4 forms a complex with MD-2 (LY96) at the cell surface:
- MD-2 binds directly to the hydrophobic portion of LPS
- The TLR4-MD-2 complex dimerizes upon LPS binding
- Dimerization brings TIR domains together for downstream signaling
Normal Function
LPS Recognition
TLR4 detects gram-negative bacterial infections:
LBP transfer: LPS-binding protein transfers LPS to CD14
CD14 presentation: CD14 presents LPS to TLR4-MD-2
Dimerization: Two TLR4-MD-2-LPS complexes dimerize
Signal transduction: TIR adaptors recruited to cytoplasmic domainSignaling Pathways
TLR4 activates two distinct pathways:
| Pathway | Adaptor | Outcome |
|---------|---------|---------|
| MyD88-dependent | MyD88, TIRAP | Early [NF-κB](/entities/nf-kb) activation, pro-inflammatory cytokines |
| TRIF-dependent | TRIF, TRAM | Late NF-κB, IRF3 activation, type I interferons |
Role in Neurodegeneration
Alzheimer's Disease
TLR4 contributes to AD pathogenesis through multiple mechanisms:
- [Aβ](/proteins/amyloid-beta) recognition: TLR4 can bind amyloid-β and trigger microglial activation[@fassbender2004]
- Neuroinflammation: TLR4 activation sustains chronic inflammation in AD brain
- DAMP sensing: HMGB1 and other DAMPs from dying [neurons](/entities/neurons) activate TLR4
- [Blood-brain barrier](/entities/blood-brain-barrier): LPS leakage across compromised BBB activates TLR4
Animal studies: TLR4 deficiency accelerates Aβ deposition, suggesting a complex role with both protective and detrimental effects[@landreth2018].
Parkinson's Disease
TLR4 is implicated in dopaminergic neuron degeneration:
- [α-synuclein](/proteins/alpha-synuclein) sensing: Aggregated α-synuclein can activate TLR4 on microglia[@kim2011]
- [Gut-brain axis](/entities/gut-brain-axis): Intestinal LPS reaches the brain via vagus nerve
- Neuroinflammation: TLR4-driven inflammation contributes to nigral degeneration
- MPTP models: TLR4 knockout mice are partially protected from MPTP toxicity
Amyotrophic Lateral Sclerosis
TLR4 expression is elevated in ALS:
- Microglial activation: TLR4 contributes to microglial reactivity in ALS spinal cord
- [TDP-43](/mechanisms/tdp-43-proteinopathy): Cytoplasmic TDP-43 aggregates may activate TLR4
- Disease progression: TLR4 levels correlate with disease severity
Traumatic Brain Injury
TLR4 mediates post-traumatic neuroinflammation:
- DAMP release: HMGB1 and HSPs released after injury activate TLR4
- Blood-brain barrier breakdown: Allows peripheral LPS entry
- Chronic inflammation: Persistent TLR4 activation may link TBI to later neurodegeneration
Therapeutic Targeting
TLR4 Antagonists
Several strategies target TLR4 in neurodegeneration:
| Agent | Mechanism | Status |
|-------|-----------|--------|
| TAK-242 (Resatorvid) | Binds TIR domain, blocks signaling | Preclinical/clinical trials |
| Eritoran | MD-2 antagonist, prevents LPS binding | Phase III (sepsis), preclinical (neuro) |
| E5564 | Synthetic lipid A analogue | Clinical development |
| Natural antagonists | Curcumin, resveratrol | Dietary supplements |
Anti-Inflammatory Combinations
TLR4 inhibition may synergize with other approaches:
- [NLRP3](/entities/nlrp3-inflammasome) inhibitors: Dual targeting of innate immune pathways
- NSAIDs: Combine with TLR4 blockade for enhanced anti-inflammatory effect
- [Microbiome](/entities/microbiome) modulation: Reduce systemic LPS burden
Key Interactions
| Partner | Function | Disease Relevance |
|---------|----------|-------------------|
| MD-2 (LY96) | LPS co-receptor | Required for signaling |
| CD14 | LPS presentation | Enhances sensitivity |
| MyD88 | Signal adaptor | NF-κB activation |
| TRIF | Signal adaptor | IRF3/interferon |
| HMGB1 | Endogenous DAMP | Neurodegeneration |
| α-synuclein | Protein aggregate | PD neuroinflammation |
Genetic Polymorphisms
TLR4 polymorphisms influence neurodegenerative disease risk:
- Asp299Gly (rs4986790): Reduced LPS responsiveness
- Thr399Ile (rs4986791): Altered signaling
- AD association: Some studies suggest modified AD risk with TLR4 variants[@balistreri2013]
Key Publications
Tahara et al. [TLR4 signaling pathways in Alzheimer's disease](https://doi.org/10.1016/j.neuint.2014.06.011). Neurochem Int. 2014;75:19-26.
Tang et al. [Toll-like receptor 4 deficiency impairs microglial activation and delays amyloid plaque formation](https://pubmed.ncbi.nlm.nih.gov/18090922/). J Neuroinflammation. 2007;4:40.
Stefanova et al. [α-synuclein activates TLR4-dependent microglial inflammatory responses](https://pubmed.ncbi.nlm.nih.gov/21530655/). J Neuroinflammation. 2011;8:138.
Bi et al. [Association of TLR4 polymorphisms with sporadic Alzheimer's disease in a Chinese Han population](https://doi.org/10.1186/s40001-018-0313-0). J Neuroinflammation. 2019;16(1):25.See Also
- [TLR4 Gene](/genes/tlr4)
- [TDP-43](/mechanisms/tdp-43-proteinopathy)
External Links
- [UniProt: O00206](https://www.uniprot.org/uniprot/O00206)
- [PDB structures](https://www.rcsb.org/search?q=uniprot:O00206)
- [GeneCards: TLR4](https://www.genecards.org/cgi-bin/carddisp.pl?gene=TLR4)
References
[Fassbender et al, The LPS receptor (CD14) links innate immunity with Alzheimer's disease (2004)](https://pubmed.ncbi.nlm.nih.gov/15177665/)
[Landreth et al, Inflammation in Alzheimer's disease and therapeutic implications (2018)](https://doi.org/10.1016/j.mcn.2018.08.008)
[Kim et al, α-Synuclein induces activation of microglia via TLR4 and NF-κB signaling (2011)](https://pubmed.ncbi.nlm.nih.gov/21530655/)
[Balistreri et al, TLR4 polymorphisms and environment: implications for neurodegenerative diseases (2013)](https://doi.org/10.1016/j.autrev.2013.10.002)From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
- [Enteric Nervous System Prion-Like Propagation Blockade](/hypothesis/h-2e7eb2ea) — <span style="color:#ffd54f;font-weight:600">0.42</span> · Target: TLR4, SNCA
Pathway Diagram
The following diagram shows the key molecular relationships involving Toll-Like Receptor 4 (TLR4) discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)